138 related articles for article (PubMed ID: 38738531)
1. Hemoglobin level and erythropoietin response in hemodialysis patients: what can we pay attention to?
Zhao Y; Zhao K; Fang J; Wang W
Ren Fail; 2024 Dec; 46(1):2353338. PubMed ID: 38738531
[No Abstract] [Full Text] [Related]
2. Serum immunoreactive erythropoietin in patients with end stage renal disease.
Gimenez LF; Watson AJ; Spivak JL
Prog Clin Biol Res; 1990; 352():493-504. PubMed ID: 2402519
[No Abstract] [Full Text] [Related]
3. Anemia in dialysis: its relation to acquired cystic kidney disease and serum levels of erythropoietin.
Férnandez A; Hortal L; Rodríguez JC; Vega N; Plaza C; Palop L
Am J Nephrol; 1991; 11(1):12-5. PubMed ID: 2048573
[TBL] [Abstract][Full Text] [Related]
4. Hemoglobin levels, quality of life, and survival.
Sadler JH; Meyer KB
Nephrol News Issues; 2007 Aug; 21(9):42-3. PubMed ID: 17722853
[No Abstract] [Full Text] [Related]
5. Circulating levels of thrombopoietin and erythropoietin in hemodialysis patients.
Otsubo Y; Nitta K; Otsubo S; Kimata N; Miwa N; Watanabe Y; Uchida K; Kawashima A; Yumura W; Akiba T; Nihei H
Acta Haematol; 2003; 109(4):209-11. PubMed ID: 12853697
[No Abstract] [Full Text] [Related]
6. [A hematocrit greater than 36 lessens mortality and hospitalization in hemodialysis].
Fernández-Gallego J; Gutiérrez C
Nefrologia; 2003; 23(2):177-8. PubMed ID: 12778885
[No Abstract] [Full Text] [Related]
7. Erythropoietin treatment: influence of haemoglobin concentration on dialyser creatinine clearance in haemodialysed patients.
Zehnder C
Nephron; 1989; 51(3):424-5. PubMed ID: 2918959
[No Abstract] [Full Text] [Related]
8. Serum erythropoietin (ESF) titers in anemia of chronic renal failure.
de Klerk G; Wilmink JM; Rosengarten PC; Vet RJ; Goudsmit R
J Lab Clin Med; 1982 Nov; 100(5):720-34. PubMed ID: 7130829
[TBL] [Abstract][Full Text] [Related]
9. [Human recombinant erythropoietin in the treatment of anemia in patients on long-term hemodialysis].
Boratyńska M; Szewczyk Z; Szepietowski T; Czyz W; Cybulski K; Bogucki J; Szczepański J
Przegl Lek; 1990; 47(11):741-5. PubMed ID: 2098840
[TBL] [Abstract][Full Text] [Related]
10. [Stability of hemoglobin levels: an indispensible paradigm change in medical management].
Zaoui P; Deray G; Ortiz JP; Rostaing L
Nephrol Ther; 2011 Feb; 7(1 Suppl 2):H5-7. PubMed ID: 21371678
[No Abstract] [Full Text] [Related]
11. Changes of endogenous erythropoietin level and iron status during a 30-month hemodialysis treatment of a group of patients.
Majdan M; Ksiazek A; Bednarek-Skublewska A; Spasiewicz D
Int Urol Nephrol; 2001; 33(3):541-6. PubMed ID: 12230292
[TBL] [Abstract][Full Text] [Related]
12. Serum erythropoietin titers in the anemia of chronic renal failure and other hematological states.
Urabe A; Saito T; Fukamachi H; Kubota M; Takaku F
Int J Cell Cloning; 1987 May; 5(3):202-8. PubMed ID: 3598244
[TBL] [Abstract][Full Text] [Related]
13. [Human recombinant erythropoietin (rH-EPO) in chronic hemodialysis patients].
Jalil R; Vaccarezza A; Jara A; Lira P; Vial S; Serrano V
Rev Med Chil; 1990 Jun; 118(6):629-34. PubMed ID: 1775783
[TBL] [Abstract][Full Text] [Related]
14. Subcutaneous erythropoietin in the treatment of renal anaemia.
Drinovec J; Varl J
Przegl Lek; 1992; 49(1-2):38-40. PubMed ID: 1455004
[TBL] [Abstract][Full Text] [Related]
15. Monitoring erythropoietin therapy for anaemia of chronic renal failure by serum erythropoietin assays.
Marsden JT; Sherwood RA; Hillis A; Peters TJ
Ann Clin Biochem; 1993 Mar; 30 ( Pt 2)():205-6. PubMed ID: 8466156
[No Abstract] [Full Text] [Related]
16. Using dynamic treatment regimes to understand erythropoietin-stimulating agent hyporesponsiveness.
Pollack AH; Oron AP; Flynn JT; Munshi R
Pediatr Nephrol; 2018 Aug; 33(8):1411-1417. PubMed ID: 29619552
[TBL] [Abstract][Full Text] [Related]
17. Hemoglobin levels and erythropoietin doses in hemodialysis and peritoneal dialysis patients in the United States.
Snyder JJ; Foley RN; Gilbertson DT; Vonesh EF; Collins AJ
J Am Soc Nephrol; 2004 Jan; 15(1):174-9. PubMed ID: 14694170
[TBL] [Abstract][Full Text] [Related]
18. Absolute and relative erythropoietin deficiency in renal anemia.
Koch KM; Radtke HW
Contrib Nephrol; 1978; 13():60-8. PubMed ID: 710139
[No Abstract] [Full Text] [Related]
19. Target hemoglobin level for EPO therapy in CKD.
Parfrey PS
Am J Kidney Dis; 2006 Jan; 47(1):171-3. PubMed ID: 16377399
[No Abstract] [Full Text] [Related]
20. [Erythropoietin and transfusions in patients with anemia of chronic renal failure origin : an update view].
Duclos J; Olea C; Aguirre H; Alvarez MC; Salgado MC
Rev Med Chil; 1995 Apr; 123(4):451-5. PubMed ID: 8525189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
